{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T19:37:13Z","timestamp":1720553833508},"reference-count":21,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T00:00:00Z","timestamp":1033430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2002,10]]},"DOI":"10.1053\/shem.2002.36926","type":"journal-article","created":{"date-parts":[[2002,11,22]],"date-time":"2002-11-22T11:28:11Z","timestamp":1037964491000},"page":"25-31","source":"Crossref","is-referenced-by-count":9,"special_numbering":"S","title":["Epoetin alfa as a supportive measure in hematologic malignancies"],"prefix":"10.1053","volume":"39","author":[{"given":"David J","family":"Straus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/shem.2002.36926_BIB1","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1093\/jnci\/91.19.1616","article-title":"Chemotherapy-induced anemia in adults: Incidence and treatment","volume":"91","author":"Groopman","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/shem.2002.36926_BIB2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/hon.663","article-title":"Erythropoietin for the treatment of anemia associated with hematological malignancy","volume":"19","author":"Littlewood","year":"2001","journal-title":"Hematol Oncol"},{"issue":"suppl 4","key":"10.1053\/shem.2002.36926_BIB3","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.1016\/S0959-8049(99)81747-X","article-title":"Anemia associated with non-platinum chemotherapy (CT) for Hodgkin's lymphoma (HL) or non-Hodgkin's lymphoma (NHL)","volume":"35","author":"Coiffier","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1053\/shem.2002.36926_BIB4","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1136\/bmj.322.7302.1560","article-title":"Fatigue in cancer","volume":"322","author":"Curt","year":"2001","journal-title":"BMJ"},{"key":"10.1053\/shem.2002.36926_BIB5","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJM199006143222401","article-title":"Decreased erythropoietin response in patients with the anemia of cancer","volume":"322","author":"Miller","year":"1990","journal-title":"N Engl J Med"},{"issue":"suppl 7","key":"10.1053\/shem.2002.36926_BIB6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0037-1963(01)90124-6","article-title":"New strategies and treatment modalities for optimizing patient outcomes","volume":"38","author":"Gabrilove","year":"2001","journal-title":"Semin Hematol"},{"key":"10.1053\/shem.2002.36926_BIB7","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJM199006143222402","article-title":"Erythropoietin treatment of anemia associated with multiple myeloma","volume":"322","author":"Ludwig","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1053\/shem.2002.36926_BIB8","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1182\/blood.V87.7.2675.bloodjournal8772675","article-title":"Recombinant human erythropoietin in transfusion-dependent anemic patients with multiple myeloma and non-Hodgkin's lymphoma-A randomized multicenter study","volume":"87","author":"\u00d6sterborg","year":"1996","journal-title":"Blood"},{"key":"10.1053\/shem.2002.36926_BIB9","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1200\/JCO.2001.19.11.2865","article-title":"Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: Results of a randomized, double-blind, placebo-controlled trial","volume":"19","author":"Littlewood","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1053\/shem.2002.36926_BIB10","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.1997.15.3.1218","article-title":"Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice","volume":"15","author":"Glaspy","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1053\/shem.2002.36926_BIB11","doi-asserted-by":"crossref","first-page":"3412","DOI":"10.1200\/JCO.1998.16.10.3412","article-title":"Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study","volume":"16","author":"Demetri","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1053\/shem.2002.36926_BIB12","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1200\/JCO.2001.19.11.2875","article-title":"Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in hemoglobin and quality of life are similar to three-times-weekly dosing","volume":"19","author":"Gabrilove","year":"2001","journal-title":"J Clin Oncol"},{"issue":"suppl 7","key":"10.1053\/shem.2002.36926_BIB13","first-page":"12","article-title":"Update on the role of epoetin alfa in hematologic malignancies and myelodysplastic syndromes","volume":"25","author":"Casadevall","year":"1998","journal-title":"Semin Oncol"},{"key":"10.1053\/shem.2002.36926_BIB14","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1365-2141.1995.tb08421.x","article-title":"The use of r-HuEpo in the treatment of anaemia related to myelodysplasia (MDS)","volume":"89","author":"Rose","year":"1995","journal-title":"Br J Haematol"},{"key":"10.1053\/shem.2002.36926_BIB15","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1182\/blood.V95.4.1175.004k51_1175_1179","article-title":"Effect of recombinant human erythropoietin combined with granulocyte\/macrophage colony-stimulating factor in the treatment of patients with myelodysplastic syndrome","volume":"95","author":"Thompson","year":"2000","journal-title":"Blood"},{"key":"10.1053\/shem.2002.36926_BIB16","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1182\/blood.V87.10.4076.bloodjournal87104076","article-title":"Maintenance treatment of the anemia of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor and erythropoietin: Evidence for in vivo synergy","volume":"87","author":"Negrin","year":"1996","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1053\/shem.2002.36926_BIB17","first-page":"526a","article-title":"Clinical and health status assessments in anemic chronic lymphocytic leukemia (CLL) patients treated with epoetin alfa (EPO)","volume":"84","author":"Rose","year":"1994","journal-title":"Blood"},{"key":"10.1053\/shem.2002.36926_BIB18","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1182\/blood.V86.12.4446.bloodjournal86124446","article-title":"Recombinant human erythropoietin in the anemia associated with multiple myeloma or non-Hodgkin's lymphoma: Dose finding and identification of predictors of response","volume":"86","author":"Cazzola","year":"1995","journal-title":"Blood"},{"key":"10.1053\/shem.2002.36926_BIB19","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1046\/j.1365-2141.2001.02715.x","article-title":"Efficacy of epoetin alfa in the treatment of anaemia of multiple myeloma","volume":"113","author":"Dammacco","year":"2001","journal-title":"Br J Haematol"},{"key":"10.1053\/shem.2002.36926_BIB20","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/cncr.10763","article-title":"Relationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapy","volume":"95","author":"Crawford","year":"2002","journal-title":"Cancer"},{"issue":"suppl 14","key":"10.1053\/shem.2002.36926_BIB21","first-page":"34","article-title":"Quality of life and treatment value in the management of hematologic malignancies","volume":"26","author":"Cella","year":"1999","journal-title":"Semin Oncol"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196302500810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196302500810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T06:27:10Z","timestamp":1583908030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196302500810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,10]]}},"alternative-id":["S0037196302500810"],"URL":"https:\/\/doi.org\/10.1053\/shem.2002.36926","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2002,10]]}}}